Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

Sweeping funding cuts threaten to undermine the innovation that has been a central part of US economic strength for decades ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

Letter, Bloomberg Distinguished Professor Jeff Coller discussed his research on the development of a new experimental protein ...

The New York-based public benefit corporation is advancing three drug candidates for the extremely rare condition.

These insights from researchers could have major implications for diseases like cancer, where gene expression goes awry.

Scientists at the Icahn School of Medicine at Mount Sinai have made an exciting discovery about how human cells make RNA, a molecule that carries important instructions inside our bodies.